Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Crow, T. J.
1978.
Clinical Research Centre Division of Psychiatry 1974–1977.
Psychological Medicine,
Vol. 8,
Issue. 3,
p.
515.
Wiles, D.
Franklin, M.
Dencker, S. J.
Johansson, R.
Lundin, L.
and
Malm, U.
1980.
Plasma fluphenazine and prolactin levels in schizophrenic patients during treatment with low and high doses of fluphenazine enanthate.
Psychopharmacology,
Vol. 71,
Issue. 2,
p.
131.
Crow, T. J.
1980.
Biochemistry of Schizophrenia and Addiction.
p.
19.
Johnstone, EC
and
Ferrier, IN
1980.
Neuroendocrine markers of CNS drug effects..
British Journal of Clinical Pharmacology,
Vol. 10,
Issue. 1,
p.
5.
Crow, T J
1980.
Molecular pathology of schizophrenia: more than one disease process?.
BMJ,
Vol. 280,
Issue. 6207,
p.
66.
Crow, T.J.
1980.
Synaptic Constituents in Health and Disease.
p.
485.
Dencker, S. J.
and
Elgen, K.
1980.
Aspects of clinical psychiatric research on depot neuroleptics: THE PRESENTATION OF TWO DOUBLE‐BLIND TRIALS WITH CIS(Z)‐CLOPENTHIXOL DECANOATE AND A WITHDRAWAL STUDY IN SCHIZOPHRENICS.
Acta Psychiatrica Scandinavica,
Vol. 61,
Issue. S279,
p.
5.
Johnstone, Eve C.
Bourne, Rachel C.
Cotes, P. Mary
Crow, T.J.
Ferrier, I.N.
Owen, F.
and
Robinson, J.D.
1980.
Ciba Foundation Symposium 74 ‐ Drug Concentrations in Neuropsychiatry.
Vol. 74,
Issue. ,
p.
99.
Johnstone, E. C.
and
Ferrier, I. N.
1981.
Methods in Clinical Pharmacology—Central Nervous System.
p.
3.
Shur, Eric
and
Checkley, Stuart
1982.
Prolactin Response to Neuroleptic Challenge.
British Journal of Psychiatry,
Vol. 140,
Issue. 4,
p.
431.
Knight, J.G
1982.
DOPAMINE-RECEPTOR-STIMULATING AUTOANTIBODIES: A POSSIBLE CAUSE OF SCHIZOPHRENIA.
The Lancet,
Vol. 320,
Issue. 8307,
p.
1073.
Cookson, J. C.
Silverstone, T.
and
Rees, Lesley
1982.
Plasma Prolactin and Growth Hormone Levels in Manic Patients Treated with Pimozide.
British Journal of Psychiatry,
Vol. 140,
Issue. 3,
p.
274.
Metz, John
Busch, Daniel A.
and
Meltzer, Herbert Y.
1982.
CLINICAL, ELECTROPHYSIOLOGICAL, AND BIOCHEMICAL EFFECTS OF DES‐TYROSINE‐γ‐ENDORPHIN IN PSYCHIATRIC PATIENTS *.
Annals of the New York Academy of Sciences,
Vol. 398,
Issue. 1,
p.
496.
Ferrier, I. N.
Cotes, P. M.
Crow, T. J.
and
Johnstone, E. C.
1982.
Gonadotrophin secretion abnormalities in chronic schizophrenia.
Psychological Medicine,
Vol. 12,
Issue. 2,
p.
263.
FERRIER, I. N.
ARENDT, J.
JOHNSTONE, E. C.
and
CROW, T. J.
1982.
REDUCED NOCTURNAL MELATONIN SECRETION IN CHRONIC SCHIZOPHRENIA: RELATIONSHIP TO BODY WEIGHT.
Clinical Endocrinology,
Vol. 17,
Issue. 2,
p.
181.
Checkley, Stuart
1982.
Clinical Neuroendocrinology.
p.
265.
Lal, Samarthji
Vasavan Nair, N.P.
Iskandar, Hani I.
Thavundayil, Joseph X.
Etienne, Pierre
Wood, Paul L.
and
Guyda, Harvey
1982.
Drug-induced growth hormone and prolactin responses in schizophrenia research.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 6,
Issue. 4-6,
p.
631.
Mitchell, James
and
Popkin, Michael
1983.
The pathophysiology of sexual dysfunction associated with antipsychotic drug therapy in males: A review.
Archives of Sexual Behavior,
Vol. 12,
Issue. 2,
p.
173.
Deakin, J. F. W.
Ferrier, I. N.
Crow, T. J.
Johnstone, E. C.
and
Lawler, P.
1983.
Effects of ECT on Pituitary Hormone Release: Relationship to Seizure, Clinical Variables and Outcome.
British Journal of Psychiatry,
Vol. 143,
Issue. 6,
p.
618.
Cross, A.J.
Ferrier, I.N.
and
Bloxham, C.A.
1983.
Dopamine D1 receptors in human parathyroid gland: In vitro and in vivo studies.
Life Sciences,
Vol. 33,
Issue. 8,
p.
743.